Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma

被引：0
|
作者：
Kroog, G. S.
Feldman, D. R.
Kondagunta, G. V.
Ginsberg, M. S.
Fischer, P. M.
Trinos, M. J.
Patil, S.
Ishill, N. M.
Motzer, R. J.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Crystal Run Healthcare, Middletown, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5037
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I trial sunitinib plus everolimus in patients with metastatic renal cell carcinoma (mRCC)
    Molina, A. M.
    Feldman, D. R.
    Ginsberg, M. S.
    Fischer, P.
    Trinos, M. J.
    Patil, S.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [2] Prediction of response to RAD001 (everolimus) in patients with metastatic renal cell carcinoma
    Seidel, C.
    Fenner, M.
    Merseburger, A.
    Heuser, M.
    Ganser, A.
    Gruenwald, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Prediction of response to RAD001 (Everolimus) in patients with metastatic renal cell carcinoma
    Seidel, C.
    Fenner, M.
    Merseburger, A.
    Heuser, M.
    Ganser, A.
    Gruenwald, V.
    ONKOLOGIE, 2010, 33 : 105 - 105
  • [4] Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
    Lim, Taekyu
    Lee, Jeeyun
    Lee, Duk Joo
    Lee, Ha Yeon
    Han, Boram
    Baek, Kyung Kee
    Ahn, Hee Kyung
    Lee, Su Jin
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kim, Kyoung-Mee
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 255 - 262
  • [5] Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
    Taekyu Lim
    Jeeyun Lee
    Duk Joo Lee
    Ha Yeon Lee
    Boram Han
    Kyung Kee Baek
    Hee Kyung Ahn
    Su Jin Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Kyoung-Mee Kim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 255 - 262
  • [6] Phase 1 Trial of Everolimus Plus Sunitinib in Patients With Metastatic Renal Cell Carcinoma
    Molina, Ana M.
    Feldman, Darren R.
    Voss, Martin H.
    Ginsberg, Michelle S.
    Baum, Michael S.
    Brocks, Dion R.
    Fischer, Patricia M.
    Trinos, Michael J.
    Patil, Sujata
    Motzer, Robert J.
    CANCER, 2012, 118 (07) : 1868 - 1876
  • [7] PHASE-3 RANDOMISED TRIAL OF EVEROLIMUS (RAD001) VS PLACEBO IN METASTATIC RENAL CELL CARCINOMA
    Escudier, B.
    Ravaud, A.
    Oudard, S.
    Hutson, T. E.
    Porta, C.
    Bracarda, S.
    Gruenwald, V.
    Thompson, J.
    Figlin, R. A.
    Motzer, R. J.
    ANNALS OF ONCOLOGY, 2008, 19 : 45 - 45
  • [8] UPDATED DATA FROM A PHASE 3 TRIAL OF EVEROLIMUS (RAD001) VERSUS PLACEBO IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Kay, A.
    Motzer, R. J.
    Figlin, R. A.
    Escudier, B.
    Oudard, S.
    Porta, C.
    Hutson, T. E.
    Bracarda, S.
    Hollaender, N.
    Urbanowitz, G.
    Ravaud, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 185 - 185
  • [9] A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC)
    Jac, J.
    Giessinger, S.
    Khan, M.
    Willis, J.
    Chiang, S.
    Amato, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC).
    Amato, R. J.
    Misellati, A.
    Khan, M.
    Chiang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 224S - 224S
12345